研究用抗体市場：適応症別、事業別、製品別、供給源別、技術別、タイプ別、エンドユーザー別-2023-2030年の世界予測

研究用抗体の世界市場は、2023年にCAGR 8.41%で62億7,468万米ドルが予測され、2030年には110億5,881万米ドルに達するという驚異的な成長を遂げると予測されています。

FPNVポジショニング・マトリックス

FPNVポジショニングマトリックスは世界の研究用抗体市場を評価するために不可欠です。事業戦略と製品満足度の主要指標を調査することで、ベンダーの包括的な評価を提供し、ユーザーが特定のニーズに基づいて情報に基づいた意思決定を行えるようにします。この高度な分析により、ベンダーは成功の度合いが異なる4つの象限に整理されます：フォアフロント（F）、パスファインダー（P）、ニッチ（N）、バイタル（V）です。

市場シェア分析

市場シェア分析では、特定の市場領域におけるベンダーの現状を洞察することができます。全体的な収益、顧客基盤、その他の主要指標に対するベンダーの貢献度を比較することで、企業が市場シェアを争う際に、自社の業績や直面している状況をより深く理解することができます。また、本分析では、調査した基準年において、特定のセクターがどの程度競合しているのか、蓄積、断片化の優位性、合併の特徴についても明らかにしています。

本レポートは、以下のポイントに関する洞察を提供します：

1.市場の浸透度：主要企業が提供する市場に関する包括的な情報を提供します。

2.市場の発展：有利な新興市場に関する詳細情報を提供し、市場の成熟セグメントにおける浸透度を分析します。

3.市場の多様化：新製品の上市、未開発地域、最近の開発、投資に関する詳細情報を提供します。

4.市場の動向：COVID-19、ロシア・ウクライナ紛争、高インフレの累積的な影響を包括的に理解することができます。

5.競合の評価と情報：主要企業の市場シェア、戦略、製品、認証、規制状況、特許状況、製造能力を網羅的に評価します。

6.製品開発およびイノベーション：将来技術、研究開発活動、画期的な製品開発に関する知的洞察を提供します。

本レポートは、以下のような質問にお答えします：

1.研究用抗体の世界市場規模および予測は？

2.予測期間中、世界の研究用抗体市場を形成するCOVID-19の阻害要因と影響は？

3.研究用抗体の世界市場において予測期間中に投資すべき製品/セグメント/アプリケーション/分野は？

4.研究用抗体の世界市場における競争戦略は？

5.研究用抗体の世界市場における技術動向と規制の枠組みは？

6.研究用抗体の世界市場における主要ベンダーの市場シェアは？

7.研究用抗体の世界市場への参入には、どのような形態や戦略的な動きが適していると考えられるか？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • ゲノミクスおよびプロテオミクス調査の人気の高まり
    • 研究用抗体の臨床試験と承認の増加
  • 抑制要因
    • 時間とコストがかかる抗体開発プロセス
  • 機会
    • 個別化医療とバイオマーカーの普及
    • 新薬開発への投資と資金の増加
  • 課題
    • 研究用抗体に関連する品質上の懸念
• 市場動向
• COVID-19の累積的な影響
• ロシア・ウクライナ紛争の累積的影響
• 高インフレの累積的影響
• ポーターのファイブフォース分析
• バリューチェーンとクリティカルパス分析
• 規制の枠組み
• 顧客のカスタマイズ

第6章 研究用抗体市場適応症別

• 免疫学
• 感染症
• 神経生物学
• 腫瘍学
• 幹細胞

第7章 研究用抗体市場：操作別

• 医薬品開発
• ゲノミクス
• プロテオミクス

第8章 研究用抗体市場：製品別

• モノクローナル抗体
• ポリクローナル抗体

第9章 研究用抗体市場：ソース別

• ヤギ
• ねずみ
• うさぎ

第10章 研究用抗体市場：技術別

• 酵素免疫測定法
• フローサイトメトリー
• 免疫蛍光
• 免疫組織化学
• 免疫沈降
• ウェスタンブロッティング

第11章 研究用抗体市場：タイプ別

• 一次抗体
• 二次抗体

第12章 研究用抗体市場：エンドユーザー別

• 学術調査機関
• 製薬およびバイオテクノロジー企業

第13章 南北アメリカの研究用抗体市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第14章 アジア太平洋地域の研究用抗体市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第15章 欧州・中東・アフリカの研究用抗体市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第16章 競合情勢

• FPNVポジショニングマトリクス
• 市場シェア分析：主要企業別
• 競合シナリオ分析：主要企業別

第17章 掲載企業一覧

第18章 付録

• ディスカッションガイド
• ライセンスと価格について

LIST OF FIGURES

• FIGURE 1. RESEARCH ANTIBODIES MARKET RESEARCH PROCESS
• FIGURE 2. RESEARCH ANTIBODIES MARKET SIZE, 2022 VS 2030
• FIGURE 3. RESEARCH ANTIBODIES MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. RESEARCH ANTIBODIES MARKET SIZE, BY INDICATION, 2022 VS 2030 (%)
• FIGURE 5. RESEARCH ANTIBODIES MARKET SIZE, BY OPERATION, 2022 VS 2030 (%)
• FIGURE 6. RESEARCH ANTIBODIES MARKET SIZE, BY PRODUCT, 2022 VS 2030 (%)
• FIGURE 7. RESEARCH ANTIBODIES MARKET SIZE, BY SOURCE, 2022 VS 2030 (%)
• FIGURE 8. RESEARCH ANTIBODIES MARKET SIZE, BY TECHNOLOGY, 2022 VS 2030 (%)
• FIGURE 9. RESEARCH ANTIBODIES MARKET SIZE, BY TYPE, 2022 VS 2030 (%)
• FIGURE 10. RESEARCH ANTIBODIES MARKET SIZE, BY END USER, 2022 VS 2030 (%)
• FIGURE 11. RESEARCH ANTIBODIES MARKET SIZE, BY REGION, 2022 VS 2030 (%)
• FIGURE 12. RESEARCH ANTIBODIES MARKET DYNAMICS
• FIGURE 13. RESEARCH ANTIBODIES MARKET SIZE, BY INDICATION, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 14. RESEARCH ANTIBODIES MARKET SIZE, BY OPERATION, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 15. RESEARCH ANTIBODIES MARKET SIZE, BY PRODUCT, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 16. RESEARCH ANTIBODIES MARKET SIZE, BY SOURCE, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 17. RESEARCH ANTIBODIES MARKET SIZE, BY TECHNOLOGY, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 18. RESEARCH ANTIBODIES MARKET SIZE, BY TYPE, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 19. RESEARCH ANTIBODIES MARKET SIZE, BY END USER, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 20. AMERICAS RESEARCH ANTIBODIES MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 21. UNITED STATES RESEARCH ANTIBODIES MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 22. ASIA-PACIFIC RESEARCH ANTIBODIES MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 23. EUROPE, MIDDLE EAST & AFRICA RESEARCH ANTIBODIES MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 24. RESEARCH ANTIBODIES MARKET, FPNV POSITIONING MATRIX, 2022
• FIGURE 25. RESEARCH ANTIBODIES MARKET SHARE, BY KEY PLAYER, 2022

LIST OF TABLES

• TABLE 1. RESEARCH ANTIBODIES MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
• TABLE 3. RESEARCH ANTIBODIES MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. RESEARCH ANTIBODIES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 5. RESEARCH ANTIBODIES MARKET SIZE, BY IMMUNOLOGY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 6. RESEARCH ANTIBODIES MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 7. RESEARCH ANTIBODIES MARKET SIZE, BY NEUROBIOLOGY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 8. RESEARCH ANTIBODIES MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. RESEARCH ANTIBODIES MARKET SIZE, BY STEM CELLS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. RESEARCH ANTIBODIES MARKET SIZE, BY OPERATION, 2018-2030 (USD MILLION)
• TABLE 11. RESEARCH ANTIBODIES MARKET SIZE, BY DRUG DEVELOPMENT, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. RESEARCH ANTIBODIES MARKET SIZE, BY GENOMICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. RESEARCH ANTIBODIES MARKET SIZE, BY PROTEOMICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. RESEARCH ANTIBODIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 15. RESEARCH ANTIBODIES MARKET SIZE, BY MONOCLONAL ANTIBODIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. RESEARCH ANTIBODIES MARKET SIZE, BY POLYCLONAL ANTIBODIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. RESEARCH ANTIBODIES MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 18. RESEARCH ANTIBODIES MARKET SIZE, BY GOAT, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. RESEARCH ANTIBODIES MARKET SIZE, BY MOUSE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. RESEARCH ANTIBODIES MARKET SIZE, BY RABBIT, BY REGION, 2018-2030 (USD MILLION)
• TABLE 21. RESEARCH ANTIBODIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 22. RESEARCH ANTIBODIES MARKET SIZE, BY ENZYME-LINKED IMMUNOSORBENT ASSAY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 23. RESEARCH ANTIBODIES MARKET SIZE, BY FLOW CYTOMETRY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 24. RESEARCH ANTIBODIES MARKET SIZE, BY IMMUNOFLUORESCENCE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 25. RESEARCH ANTIBODIES MARKET SIZE, BY IMMUNOHISTOCHEMISTRY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 26. RESEARCH ANTIBODIES MARKET SIZE, BY IMMUNOPRECIPITATION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 27. RESEARCH ANTIBODIES MARKET SIZE, BY WESTERN BLOTTING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 28. RESEARCH ANTIBODIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 29. RESEARCH ANTIBODIES MARKET SIZE, BY PRIMARY ANTIBODIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 30. RESEARCH ANTIBODIES MARKET SIZE, BY SECONDARY ANTIBODIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 31. RESEARCH ANTIBODIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 32. RESEARCH ANTIBODIES MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 33. RESEARCH ANTIBODIES MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 34. AMERICAS RESEARCH ANTIBODIES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 35. AMERICAS RESEARCH ANTIBODIES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 36. AMERICAS RESEARCH ANTIBODIES MARKET SIZE, BY OPERATION, 2018-2030 (USD MILLION)
• TABLE 37. AMERICAS RESEARCH ANTIBODIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 38. AMERICAS RESEARCH ANTIBODIES MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 39. AMERICAS RESEARCH ANTIBODIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 40. AMERICAS RESEARCH ANTIBODIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 41. AMERICAS RESEARCH ANTIBODIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 42. ARGENTINA RESEARCH ANTIBODIES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 43. ARGENTINA RESEARCH ANTIBODIES MARKET SIZE, BY OPERATION, 2018-2030 (USD MILLION)
• TABLE 44. ARGENTINA RESEARCH ANTIBODIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 45. ARGENTINA RESEARCH ANTIBODIES MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 46. ARGENTINA RESEARCH ANTIBODIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 47. ARGENTINA RESEARCH ANTIBODIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 48. ARGENTINA RESEARCH ANTIBODIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 49. BRAZIL RESEARCH ANTIBODIES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 50. BRAZIL RESEARCH ANTIBODIES MARKET SIZE, BY OPERATION, 2018-2030 (USD MILLION)
• TABLE 51. BRAZIL RESEARCH ANTIBODIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 52. BRAZIL RESEARCH ANTIBODIES MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 53. BRAZIL RESEARCH ANTIBODIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 54. BRAZIL RESEARCH ANTIBODIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 55. BRAZIL RESEARCH ANTIBODIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 56. CANADA RESEARCH ANTIBODIES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 57. CANADA RESEARCH ANTIBODIES MARKET SIZE, BY OPERATION, 2018-2030 (USD MILLION)
• TABLE 58. CANADA RESEARCH ANTIBODIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 59. CANADA RESEARCH ANTIBODIES MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 60. CANADA RESEARCH ANTIBODIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 61. CANADA RESEARCH ANTIBODIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 62. CANADA RESEARCH ANTIBODIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 63. MEXICO RESEARCH ANTIBODIES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 64. MEXICO RESEARCH ANTIBODIES MARKET SIZE, BY OPERATION, 2018-2030 (USD MILLION)
• TABLE 65. MEXICO RESEARCH ANTIBODIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 66. MEXICO RESEARCH ANTIBODIES MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 67. MEXICO RESEARCH ANTIBODIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 68. MEXICO RESEARCH ANTIBODIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 69. MEXICO RESEARCH ANTIBODIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 70. UNITED STATES RESEARCH ANTIBODIES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 71. UNITED STATES RESEARCH ANTIBODIES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 72. UNITED STATES RESEARCH ANTIBODIES MARKET SIZE, BY OPERATION, 2018-2030 (USD MILLION)
• TABLE 73. UNITED STATES RESEARCH ANTIBODIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 74. UNITED STATES RESEARCH ANTIBODIES MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 75. UNITED STATES RESEARCH ANTIBODIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 76. UNITED STATES RESEARCH ANTIBODIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 77. UNITED STATES RESEARCH ANTIBODIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 78. ASIA-PACIFIC RESEARCH ANTIBODIES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 79. ASIA-PACIFIC RESEARCH ANTIBODIES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 80. ASIA-PACIFIC RESEARCH ANTIBODIES MARKET SIZE, BY OPERATION, 2018-2030 (USD MILLION)
• TABLE 81. ASIA-PACIFIC RESEARCH ANTIBODIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 82. ASIA-PACIFIC RESEARCH ANTIBODIES MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 83. ASIA-PACIFIC RESEARCH ANTIBODIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 84. ASIA-PACIFIC RESEARCH ANTIBODIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 85. ASIA-PACIFIC RESEARCH ANTIBODIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 86. AUSTRALIA RESEARCH ANTIBODIES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 87. AUSTRALIA RESEARCH ANTIBODIES MARKET SIZE, BY OPERATION, 2018-2030 (USD MILLION)
• TABLE 88. AUSTRALIA RESEARCH ANTIBODIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 89. AUSTRALIA RESEARCH ANTIBODIES MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 90. AUSTRALIA RESEARCH ANTIBODIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 91. AUSTRALIA RESEARCH ANTIBODIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 92. AUSTRALIA RESEARCH ANTIBODIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 93. CHINA RESEARCH ANTIBODIES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 94. CHINA RESEARCH ANTIBODIES MARKET SIZE, BY OPERATION, 2018-2030 (USD MILLION)
• TABLE 95. CHINA RESEARCH ANTIBODIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 96. CHINA RESEARCH ANTIBODIES MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 97. CHINA RESEARCH ANTIBODIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 98. CHINA RESEARCH ANTIBODIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 99. CHINA RESEARCH ANTIBODIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 100. INDIA RESEARCH ANTIBODIES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 101. INDIA RESEARCH ANTIBODIES MARKET SIZE, BY OPERATION, 2018-2030 (USD MILLION)
• TABLE 102. INDIA RESEARCH ANTIBODIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 103. INDIA RESEARCH ANTIBODIES MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 104. INDIA RESEARCH ANTIBODIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 105. INDIA RESEARCH ANTIBODIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 106. INDIA RESEARCH ANTIBODIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 107. INDONESIA RESEARCH ANTIBODIES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 108. INDONESIA RESEARCH ANTIBODIES MARKET SIZE, BY OPERATION, 2018-2030 (USD MILLION)
• TABLE 109. INDONESIA RESEARCH ANTIBODIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 110. INDONESIA RESEARCH ANTIBODIES MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 111. INDONESIA RESEARCH ANTIBODIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 112. INDONESIA RESEARCH ANTIBODIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 113. INDONESIA RESEARCH ANTIBODIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 114. JAPAN RESEARCH ANTIBODIES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 115. JAPAN RESEARCH ANTIBODIES MARKET SIZE, BY OPERATION, 2018-2030 (USD MILLION)
• TABLE 116. JAPAN RESEARCH ANTIBODIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 117. JAPAN RESEARCH ANTIBODIES MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 118. JAPAN RESEARCH ANTIBODIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 119. JAPAN RESEARCH ANTIBODIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 120. JAPAN RESEARCH ANTIBODIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 121. MALAYSIA RESEARCH ANTIBODIES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 122. MALAYSIA RESEARCH ANTIBODIES MARKET SIZE, BY OPERATION, 2018-2030 (USD MILLION)
• TABLE 123. MALAYSIA RESEARCH ANTIBODIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 124. MALAYSIA RESEARCH ANTIBODIES MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 125. MALAYSIA RESEARCH ANTIBODIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 126. MALAYSIA RESEARCH ANTIBODIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 127. MALAYSIA RESEARCH ANTIBODIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 128. PHILIPPINES RESEARCH ANTIBODIES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 129. PHILIPPINES RESEARCH ANTIBODIES MARKET SIZE, BY OPERATION, 2018-2030 (USD MILLION)
• TABLE 130. PHILIPPINES RESEARCH ANTIBODIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 131. PHILIPPINES RESEARCH ANTIBODIES MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 132. PHILIPPINES RESEARCH ANTIBODIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 133. PHILIPPINES RESEARCH ANTIBODIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 134. PHILIPPINES RESEARCH ANTIBODIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 135. SINGAPORE RESEARCH ANTIBODIES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 136. SINGAPORE RESEARCH ANTIBODIES MARKET SIZE, BY OPERATION, 2018-2030 (USD MILLION)
• TABLE 137. SINGAPORE RESEARCH ANTIBODIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 138. SINGAPORE RESEARCH ANTIBODIES MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 139. SINGAPORE RESEARCH ANTIBODIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 140. SINGAPORE RESEARCH ANTIBODIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 141. SINGAPORE RESEARCH ANTIBODIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 142. SOUTH KOREA RESEARCH ANTIBODIES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 143. SOUTH KOREA RESEARCH ANTIBODIES MARKET SIZE, BY OPERATION, 2018-2030 (USD MILLION)
• TABLE 144. SOUTH KOREA RESEARCH ANTIBODIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 145. SOUTH KOREA RESEARCH ANTIBODIES MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 146. SOUTH KOREA RESEARCH ANTIBODIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 147. SOUTH KOREA RESEARCH ANTIBODIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 148. SOUTH KOREA RESEARCH ANTIBODIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 149. TAIWAN RESEARCH ANTIBODIES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 150. TAIWAN RESEARCH ANTIBODIES MARKET SIZE, BY OPERATION, 2018-2030 (USD MILLION)
• TABLE 151. TAIWAN RESEARCH ANTIBODIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 152. TAIWAN RESEARCH ANTIBODIES MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 153. TAIWAN RESEARCH ANTIBODIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 154. TAIWAN RESEARCH ANTIBODIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 155. TAIWAN RESEARCH ANTIBODIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 156. THAILAND RESEARCH ANTIBODIES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 157. THAILAND RESEARCH ANTIBODIES MARKET SIZE, BY OPERATION, 2018-2030 (USD MILLION)
• TABLE 158. THAILAND RESEARCH ANTIBODIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 159. THAILAND RESEARCH ANTIBODIES MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 160. THAILAND RESEARCH ANTIBODIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 161. THAILAND RESEARCH ANTIBODIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 162. THAILAND RESEARCH ANTIBODIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 163. VIETNAM RESEARCH ANTIBODIES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 164. VIETNAM RESEARCH ANTIBODIES MARKET SIZE, BY OPERATION, 2018-2030 (USD MILLION)
• TABLE 165. VIETNAM RESEARCH ANTIBODIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 166. VIETNAM RESEARCH ANTIBODIES MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 167. VIETNAM RESEARCH ANTIBODIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 168. VIETNAM RESEARCH ANTIBODIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 169. VIETNAM RESEARCH ANTIBODIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 170. EUROPE, MIDDLE EAST & AFRICA RESEARCH ANTIBODIES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 171. EUROPE, MIDDLE EAST & AFRICA RESEARCH ANTIBODIES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 172. EUROPE, MIDDLE EAST & AFRICA RESEARCH ANTIBODIES MARKET SIZE, BY OPERATION, 2018-2030 (USD MILLION)
• TABLE 173. EUROPE, MIDDLE EAST & AFRICA RESEARCH ANTIBODIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 174. EUROPE, MIDDLE EAST & AFRICA RESEARCH ANTIBODIES MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 175. EUROPE, MIDDLE EAST & AFRICA RESEARCH ANTIBODIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 176. EUROPE, MIDDLE EAST & AFRICA RESEARCH ANTIBODIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 177. EUROPE, MIDDLE EAST & AFRICA RESEARCH ANTIBODIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 178. DENMARK RESEARCH ANTIBODIES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 179. DENMARK RESEARCH ANTIBODIES MARKET SIZE, BY OPERATION, 2018-2030 (USD MILLION)
• TABLE 180. DENMARK RESEARCH ANTIBODIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 181. DENMARK RESEARCH ANTIBODIES MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 182. DENMARK RESEARCH ANTIBODIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 183. DENMARK RESEARCH ANTIBODIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 184. DENMARK RESEARCH ANTIBODIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 185. EGYPT RESEARCH ANTIBODIES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 186. EGYPT RESEARCH ANTIBODIES MARKET SIZE, BY OPERATION, 2018-2030 (USD MILLION)
• TABLE 187. EGYPT RESEARCH ANTIBODIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 188. EGYPT RESEARCH ANTIBODIES MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 189. EGYPT RESEARCH ANTIBODIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 190. EGYPT RESEARCH ANTIBODIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 191. EGYPT RESEARCH ANTIBODIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 192. FINLAND RESEARCH ANTIBODIES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 193. FINLAND RESEARCH ANTIBODIES MARKET SIZE, BY OPERATION, 2018-2030 (USD MILLION)
• TABLE 194. FINLAND RESEARCH ANTIBODIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 195. FINLAND RESEARCH ANTIBODIES MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 196. FINLAND RESEARCH ANTIBODIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 197. FINLAND RESEARCH ANTIBODIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 198. FINLAND RESEARCH ANTIBODIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 199. FRANCE RESEARCH ANTIBODIES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 200. FRANCE RESEARCH ANTIBODIES MARKET SIZE, BY OPERATION, 2018-2030 (USD MILLION)
• TABLE 201. FRANCE RESEARCH ANTIBODIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 202. FRANCE RESEARCH ANTIBODIES MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 203. FRANCE RESEARCH ANTIBODIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 204. FRANCE RESEARCH ANTIBODIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 205. FRANCE RESEARCH ANTIBODIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 206. GERMANY RESEARCH ANTIBODIES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 207. GERMANY RESEARCH ANTIBODIES MARKET SIZE, BY OPERATION, 2018-2030 (USD MILLION)
• TABLE 208. GERMANY RESEARCH ANTIBODIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 209. GERMANY RESEARCH ANTIBODIES MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 210. GERMANY RESEARCH ANTIBODIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 211. GERMANY RESEARCH ANTIBODIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 212. GERMANY RESEARCH ANTIBODIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 213. ISRAEL RESEARCH ANTIBODIES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 214. ISRAEL RESEARCH ANTIBODIES MARKET SIZE, BY OPERATION, 2018-2030 (USD MILLION)
• TABLE 215. ISRAEL RESEARCH ANTIBODIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 216. ISRAEL RESEARCH ANTIBODIES MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 217. ISRAEL RESEARCH ANTIBODIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 218. ISRAEL RESEARCH ANTIBODIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 219. ISRAEL RESEARCH ANTIBODIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 220. ITALY RESEARCH ANTIBODIES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 221. ITALY RESEARCH ANTIBODIES MARKET SIZE, BY OPERATION, 2018-2030 (USD MILLION)
• TABLE 222. ITALY RESEARCH ANTIBODIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 223. ITALY RESEARCH ANTIBODIES MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 224. ITALY RESEARCH ANTIBODIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 225. ITALY RESEARCH ANTIBODIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 226. ITALY RESEARCH ANTIBODIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 227. NETHERLANDS RESEARCH ANTIBODIES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 228. NETHERLANDS RESEARCH ANTIBODIES MARKET SIZE, BY OPERATION, 2018-2030 (USD MILLION)
• TABLE 229. NETHERLANDS RESEARCH ANTIBODIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 230. NETHERLANDS RESEARCH ANTIBODIES MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 231. NETHERLANDS RESEARCH ANTIBODIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 232. NETHERLANDS RESEARCH ANTIBODIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 233. NETHERLANDS RESEARCH ANTIBODIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 234. NIGERIA RESEARCH ANTIBODIES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 235. NIGERIA RESEARCH ANTIBODIES MARKET SIZE, BY OPERATION, 2018-2030 (USD MILLION)
• TABLE 236. NIGERIA RESEARCH ANTIBODIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 237. NIGERIA RESEARCH ANTIBODIES MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 238. NIGERIA RESEARCH ANTIBODIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 239. NIGERIA RESEARCH ANTIBODIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 240. NIGERIA RESEARCH ANTIBODIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 241. NORWAY RESEARCH ANTIBODIES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 242. NORWAY RESEARCH ANTIBODIES MARKET SIZE, BY OPERATION, 2018-2030 (USD MILLION)
• TABLE 243. NORWAY RESEARCH ANTIBODIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 244. NORWAY RESEARCH ANTIBODIES MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 245. NORWAY RESEARCH ANTIBODIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 246. NORWAY RESEARCH ANTIBODIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 247. NORWAY RESEARCH ANTIBODIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 248. POLAND RESEARCH ANTIBODIES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 249. POLAND RESEARCH ANTIBODIES MARKET SIZE, BY OPERATION, 2018-2030 (USD MILLION)
• TABLE 250. POLAND RESEARCH ANTIBODIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 251. POLAND RESEARCH ANTIBODIES MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 252. POLAND RESEARCH ANTIBODIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 253. POLAND RESEARCH ANTIBODIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 254. POLAND RESEARCH ANTIBODIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 255. QATAR RESEARCH ANTIBODIES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 256. QATAR RESEARCH ANTIBODIES MARKET SIZE, BY OPERATION, 2018-2030 (USD MILLION)
• TABLE 257. QATAR RESEARCH ANTIBODIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 258. QATAR RESEARCH ANTIBODIES MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 259. QATAR RESEARCH ANTIBODIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 260. QATAR RESEARCH ANTIBODIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 261. QATAR RESEARCH ANTIBODIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 262. RUSSIA RESEARCH ANTIBODIES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 263. RUSSIA RESEARCH ANTIBODIES MARKET SIZE, BY OPERATION, 2018-2030 (USD MILLION)
• TABLE 264. RUSSIA RESEARCH ANTIBODIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 265. RUSSIA RESEARCH ANTIBODIES MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 266. RUSSIA RESEARCH ANTIBODIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 267. RUSSIA RESEARCH ANTIBODIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 268. RUSSIA RESEARCH ANTIBODIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 269. SAUDI ARABIA RESEARCH ANTIBODIES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 270. SAUDI ARABIA RESEARCH ANTIBODIES MARKET SIZE, BY OPERATION, 2018-2030 (USD MILLION)
• TABLE 271. SAUDI ARABIA RESEARCH ANTIBODIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 272. SAUDI ARABIA RESEARCH ANTIBODIES MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 273. SAUDI ARABIA RESEARCH ANTIBODIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 274. SAUDI ARABIA RESEARCH ANTIBODIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 275. SAUDI ARABIA RESEARCH ANTIBODIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 276. SOUTH AFRICA RESEARCH ANTIBODIES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 277. SOUTH AFRICA RESEARCH ANTIBODIES MARKET SIZE, BY OPERATION, 2018-2030 (USD MILLION)
• TABLE 278. SOUTH AFRICA RESEARCH ANTIBODIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 279. SOUTH AFRICA RESEARCH ANTIBODIES MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 280. SOUTH AFRICA RESEARCH ANTIBODIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 281. SOUTH AFRICA RESEARCH ANTIBODIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 282. SOUTH AFRICA RESEARCH ANTIBODIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 283. SPAIN RESEARCH ANTIBODIES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 284. SPAIN RESEARCH ANTIBODIES MARKET SIZE, BY OPERATION, 2018-2030 (USD MILLION)
• TABLE 285. SPAIN RESEARCH ANTIBODIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 286. SPAIN RESEARCH ANTIBODIES MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 287. SPAIN RESEARCH ANTIBODIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 288. SPAIN RESEARCH ANTIBODIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 289. SPAIN RESEARCH ANTIBODIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 290. SWEDEN RESEARCH ANTIBODIES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 291. SWEDEN RESEARCH ANTIBODIES MARKET SIZE, BY OPERATION, 2018-2030 (USD MILLION)
• TABLE 292. SWEDEN RESEARCH ANTIBODIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 293. SWEDEN RESEARCH ANTIBODIES MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 294. SWEDEN RESEARCH ANTIBODIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 295. SWEDEN RESEARCH ANTIBODIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 296. SWEDEN RESEARCH ANTIBODIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 297. SWITZERLAND RESEARCH ANTIBODIES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 298. SWITZERLAND RESEARCH ANTIBODIES MARKET SIZE, BY OPERATION, 2018-2030 (USD MILLION)
• TABLE 299. SWITZERLAND RESEARCH ANTIBODIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 300. SWITZERLAND RESEARCH ANTIBODIES MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 301. SWITZERLAND RESEARCH ANTIBODIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 302. SWITZERLAND RESEARCH ANTIBODIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 303. SWITZERLAND RESEARCH ANTIBODIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 304. TURKEY RESEARCH ANTIBODIES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 305. TURKEY RESEARCH ANTIBODIES MARKET SIZE, BY OPERATION, 2018-2030 (USD MILLION)
• TABLE 306. TURKEY RESEARCH ANTIBODIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 307. TURKEY RESEARCH ANTIBODIES MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 308. TURKEY RESEARCH ANTIBODIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 309. TURKEY RESEARCH ANTIBODIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 310. TURKEY RESEARCH ANTIBODIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 311. UNITED ARAB EMIRATES RESEARCH ANTIBODIES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 312. UNITED ARAB EMIRATES RESEARCH ANTIBODIES MARKET SIZE, BY OPERATION, 2018-2030 (USD MILLION)
• TABLE 313. UNITED ARAB EMIRATES RESEARCH ANTIBODIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 314. UNITED ARAB EMIRATES RESEARCH ANTIBODIES MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 315. UNITED ARAB EMIRATES RESEARCH ANTIBODIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 316. UNITED ARAB EMIRATES RESEARCH ANTIBODIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 317. UNITED ARAB EMIRATES RESEARCH ANTIBODIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 318. UNITED KINGDOM RESEARCH ANTIBODIES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 319. UNITED KINGDOM RESEARCH ANTIBODIES MARKET SIZE, BY OPERATION, 2018-2030 (USD MILLION)
• TABLE 320. UNITED KINGDOM RESEARCH ANTIBODIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 321. UNITED KINGDOM RESEARCH ANTIBODIES MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 322. UNITED KINGDOM RESEARCH ANTIBODIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 323. UNITED KINGDOM RESEARCH ANTIBODIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 324. UNITED KINGDOM RESEARCH ANTIBODIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 325. RESEARCH ANTIBODIES MARKET, FPNV POSITIONING MATRIX, 2022
• TABLE 326. RESEARCH ANTIBODIES MARKET SHARE, BY KEY PLAYER, 2022
• TABLE 327. RESEARCH ANTIBODIES MARKET LICENSE & PRICING

The Global Research Antibodies Market is forecasted to grow significantly, with a projected USD 6,274.68 million in 2023 at a CAGR of 8.41% and expected to reach a staggering USD 11,058.81 million by 2030.

The Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and High Inflation is expected to have significant long-term effects on the Global Research Antibodies Market. The ongoing research considers the changes in consumer behavior, supply chain disruptions, and government interventions caused by the pandemic. Similarly, the report considers the ongoing political and economic uncertainty in Eastern Europe caused by the Russia-Ukraine Conflict and its potential implications for demand-supply balances, pressure on pricing variants, and import/export and trading. Additionally, the report addresses the impact of High Inflation on the global economy and details fiscal policies measuring and reducing its effects on demand, supply, cash flow, and currency exchange.

Market Segmentation & Coverage:

This research report categorizes the Global Research Antibodies Market in order to forecast the revenues and analyze trends in each of following sub-markets:

Based on Indication, market is studied across Immunology, Infectious Diseases, Neurobiology, Oncology, and Stem Cells. The Immunology commanded largest market share of 23.46% in 2022, followed by Oncology.

Based on Operation, market is studied across Drug Development, Genomics, and Proteomics. The Drug Development commanded largest market share of 61.23% in 2022, followed by Genomics.

Based on Product, market is studied across Monoclonal Antibodies and Polyclonal Antibodies. The Monoclonal Antibodies commanded largest market share of 86.39% in 2022, followed by Polyclonal Antibodies.

Based on Source, market is studied across Goat, Mouse, and Rabbit. The Rabbit commanded largest market share of 22.39% in 2022, followed by Mouse.

Based on Technology, market is studied across Enzyme-Linked Immunosorbent Assay, Flow Cytometry, Immunofluorescence, Immunohistochemistry, Immunoprecipitation, and Western Blotting. The Western Blotting commanded largest market share of 23.20% in 2022, followed by Flow Cytometry.

Based on Type, market is studied across Primary Antibodies and Secondary Antibodies. The Primary Antibodies commanded largest market share of 67.13% in 2022, followed by Secondary Antibodies.

Based on End User, market is studied across Academic & Research Institutes and Pharmaceutical & Biotechnology Companies. The Pharmaceutical & Biotechnology Companies commanded largest market share of 51.88% in 2022, followed by Academic & Research Institutes.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Europe, Middle East & Africa commanded largest market share of 43.48% in 2022, followed by Americas.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is essential for assessing the Global Research Antibodies Market. It provides a comprehensive evaluation of vendors by examining key metrics within Business Strategy and Product Satisfaction, allowing users to make informed decisions based on their specific needs. This advanced analysis then organizes these vendors into four distinct quadrants, which represent varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital(V).

Market Share Analysis:

The Market Share Analysis offers an insightful look at the current state of vendors in a particular market space. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share. The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players

2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets

3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments

4. Market Trends: Provides comprehensive understanding of the Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and the High Inflation

5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players

6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Research Antibodies Market?

2. What are the inhibiting factors and impact of COVID-19 shaping the Global Research Antibodies Market during the forecast period?

3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Research Antibodies Market?

4. What is the competitive strategic window for opportunities in the Global Research Antibodies Market?

5. What are the technology trends and regulatory frameworks in the Global Research Antibodies Market?

6. What is the market share of the leading vendors in the Global Research Antibodies Market?

7. What modes and strategic moves are considered suitable for entering the Global Research Antibodies Market?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Limitations
• 1.7. Assumptions
• 1.8. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

• 4.1. Introduction
• 4.2. Research Antibodies Market, by Indication, 2022 vs 2030
• 4.3. Research Antibodies Market, by Operation, 2022 vs 2030
• 4.4. Research Antibodies Market, by Product, 2022 vs 2030
• 4.5. Research Antibodies Market, by Source, 2022 vs 2030
• 4.6. Research Antibodies Market, by Technology, 2022 vs 2030
• 4.7. Research Antibodies Market, by Type, 2022 vs 2030
• 4.8. Research Antibodies Market, by End User, 2022 vs 2030
• 4.9. Research Antibodies Market, by Region, 2022 vs 2030

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Rising Popularity of Genomics and Proteomics Research
    • 5.1.1.2. Increasing Clinical Trials and Approvals of Research Antibodies
  • 5.1.2. Restraints
    • 5.1.2.1. Time and Cost Consuming Antibody Development Processes
  • 5.1.3. Opportunities
    • 5.1.3.1. Proliferation of Personalized Medicine and Biomarkers
    • 5.1.3.2. Increasing Investment and Funding for Novel Drug Development
  • 5.1.4. Challenges
    • 5.1.4.1. Quality Concerns Associated with Research Antibodies
• 5.2. Market Trends
• 5.3. Cumulative Impact of COVID-19
• 5.4. Cumulative Impact of Russia-Ukraine Conflict
• 5.5. Cumulative Impact of High Inflation
• 5.6. Porter's Five Forces Analysis
  • 5.6.1. Threat of New Entrants
  • 5.6.2. Threat of Substitutes
  • 5.6.3. Bargaining Power of Customers
  • 5.6.4. Bargaining Power of Suppliers
  • 5.6.5. Industry Rivalry
• 5.7. Value Chain & Critical Path Analysis
• 5.8. Regulatory Framework
• 5.9. Client Customization

6. Research Antibodies Market, by Indication

• 6.1. Introduction
• 6.2. Immunology
• 6.3. Infectious Diseases
• 6.4. Neurobiology
• 6.5. Oncology
• 6.6. Stem Cells

7. Research Antibodies Market, by Operation

• 7.1. Introduction
• 7.2. Drug Development
• 7.3. Genomics
• 7.4. Proteomics

8. Research Antibodies Market, by Product

• 8.1. Introduction
• 8.2. Monoclonal Antibodies
• 8.3. Polyclonal Antibodies

9. Research Antibodies Market, by Source

• 9.1. Introduction
• 9.2. Goat
• 9.3. Mouse
• 9.4. Rabbit

10. Research Antibodies Market, by Technology

• 10.1. Introduction
• 10.2. Enzyme-Linked Immunosorbent Assay
• 10.3. Flow Cytometry
• 10.4. Immunofluorescence
• 10.5. Immunohistochemistry
• 10.6. Immunoprecipitation
• 10.7. Western Blotting

11. Research Antibodies Market, by Type

• 11.1. Introduction
• 11.2. Primary Antibodies
• 11.3. Secondary Antibodies

12. Research Antibodies Market, by End User

• 12.1. Introduction
• 12.2. Academic & Research Institutes
• 12.3. Pharmaceutical & Biotechnology Companies

13. Americas Research Antibodies Market

• 13.1. Introduction
• 13.2. Argentina
• 13.3. Brazil
• 13.4. Canada
• 13.5. Mexico
• 13.6. United States

14. Asia-Pacific Research Antibodies Market

• 14.1. Introduction
• 14.2. Australia
• 14.3. China
• 14.4. India
• 14.5. Indonesia
• 14.6. Japan
• 14.7. Malaysia
• 14.8. Philippines
• 14.9. Singapore
• 14.10. South Korea
• 14.11. Taiwan
• 14.12. Thailand
• 14.13. Vietnam

15. Europe, Middle East & Africa Research Antibodies Market

• 15.1. Introduction
• 15.2. Denmark
• 15.3. Egypt
• 15.4. Finland
• 15.5. France
• 15.6. Germany
• 15.7. Israel
• 15.8. Italy
• 15.9. Netherlands
• 15.10. Nigeria
• 15.11. Norway
• 15.12. Poland
• 15.13. Qatar
• 15.14. Russia
• 15.15. Saudi Arabia
• 15.16. South Africa
• 15.17. Spain
• 15.18. Sweden
• 15.19. Switzerland
• 15.20. Turkey
• 15.21. United Arab Emirates
• 15.22. United Kingdom

16. Competitive Landscape

• 16.1. FPNV Positioning Matrix
• 16.2. Market Share Analysis, By Key Player
• 16.3. Competitive Scenario Analysis, By Key Player

17. List of Company Mentioned

18. Appendix

• 18.1. Discussion Guide
• 18.2. License & Pricing